Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Seth Rudnick
AddedMar 31, 2024
UpdatedMay 31, 2026
Seth Rudnick

Seth Rudnick

Board Member, Square 1 Bank

Crunchbase

Seth Rudnick's Career

Square 1 Bank
Square 1 Bank

Durham, NC, US

Board Member· Board
Liquidia
Liquidia

Morrisville, NC, US

Board Member· Board
G1 Therapeutics
G1 Therapeutics

Triangle (historical), NC, US

Board Member· Board
Abyrx
Abyrx

Irvington, NY, US

Board Member· Board
Artizan Biosciences
Artizan Biosciences

Durham, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Seth Rudnick's Career

Square 1 Bank
Square 1 Bank
Investment FirmInvestment Firm02005Durham, NC, US
Board Member· Board

Leadership at Square 1 Bank

Robert S MuehlenbeckRobert S MuehlenbeckBoard Member
Chris WoolleyChris WoolleyFounder
Kirk WycoffKirk WycoffBoard Member
Daniel R Mathis \"Dan\"Daniel R Mathis \"Dan\"Board Member
Rob UsdanRob UsdanBoard Member
Susan G CaseySusan G CaseyBoard Member
Liquidia
Liquidia
Public$415.9M752004Morrisville, NC, US
Board Member· Board

Leadership at Liquidia

Joseph DeSimoneJoseph DeSimoneFounder
Stephen BlochStephen BlochBoard Member

Similar to Liquidia

Lung BiotechnologyLung BiotechnologySilver Spring, MD, USPharmaceuticalsest. 1997Lung BiotechnologySilver Spring, MD, US · est. 1997

Lung Biotechnology PBC: Researching, developing, and marketing therapies for pulmonary arterial hypertension.

Public125
Liquid BiotechLiquid BiotechPhiladelphia, PA, USBlood Testsest. 2012Liquid BiotechPhiladelphia, PA, US · est. 2012

Liquid Biotech USA: Developing non-invasive blood tests for a healthier future.

Seed · $2M6
United TherapeuticsUnited TherapeuticsSilver Spring, MD, USPharmaceuticalsest. 1996United TherapeuticsSilver Spring, MD, US · est. 1996

United Therapeutics, a Maryland-based biotech firm, develops pharmaceuticals for vascular diseases using synthetic prostacyclin.

Public985
PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
G1 Therapeutics
G1 Therapeutics
Public$697.4M1702008Triangle (historical), NC, US
Board Member· Board

Leadership at G1 Therapeutics

Cynthia SchwalmCynthia SchwalmBoard Member
Glenn MuirGlenn MuirBoard Member
Norman SharplessNorman SharplessFounder
Jack BaileyJack BaileyBoard Member
Garry NicholsonGarry NicholsonBoard Member
Cynthia L FlowersCynthia L FlowersBoard Member
Abyrx
Abyrx
Series A$10M202013Irvington, NY, US
Board Member· Board

Leadership at Abyrx

John J. PacificoJohn J. PacificoBoard Member
Alan J. LevyAlan J. LevyBoard Member
Brent AhrensBrent AhrensBoard Member
Gary CohnGary CohnBoard Member
John SfondriniJohn SfondriniBoard Member
Artizan Biosciences
Artizan Biosciences
Series A$33.9M262016Durham, NC, US
Board Member· Board

Leadership at Artizan Biosciences

Christy ShafferChristy ShafferBoard Member
Moncef SlaouiMoncef SlaouiBoard Member
Richard FlavellRichard FlavellCo-Founder
Marcel de ZoeteMarcel de ZoeteCo-Founder
Noah PalmNoah PalmCo-Founder
Bridget MartellBridget MartellCEO

Seth Rudnick's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Seth Rudnick

Steven HealySteven HealyBoard Member · Peytant SolutionsTom PetroTom PetroBoard Member · UnivestJamie ReynoldsJamie ReynoldsBoard Member · OrthoFiSerbousek JonSerbousek JonBoard Member · BioCrossroadsSean K. CarlsonSean K. CarlsonCo-Founder · OrthoScienceRick EpsteinRick EpsteinBoard Member · Sonoma Orthopedic Products